Kyle Kolaja

Title: Innovations by Kyle Kolaja in Renal Tubule Injury Prediction

Introduction

Kyle Kolaja is an accomplished inventor based in San Mateo, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in predicting renal tubule injury. Her innovative work has led to the development of a patented invention that holds promise for improving patient outcomes.

Latest Patents

Kyle Kolaja holds a patent for "Reagent sets and gene signatures for renal tubule injury." This invention discloses reagent sets and gene signatures that can predict the onset of renal tubule injury in a subject. The invention provides a necessary set of 186 genes that are useful for generating signatures of varying size and performance, capable of predicting the onset of renal tubule injury. Additionally, it offers methods, apparatuses, and reagents that are useful for predicting future renal tubule injury based on the expression levels of genes in the signatures. One particular embodiment of the invention provides a method to predict whether a compound will induce renal tubule injury using gene expression data from sub-acute treatments.

Career Highlights

Kyle Kolaja is currently employed at Entelos, Inc., where she continues to advance her research and innovations. Her work is characterized by a strong focus on the intersection of genetics and renal health, making her a valuable asset in the field of medical research.

Collaborations

Kyle has collaborated with notable colleagues such as Georges Natsoulis and Mark Fielden, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kyle Kolaja's contributions to the field of renal tubule injury prediction through her patented invention exemplify her dedication to advancing medical diagnostics. Her work not only enhances our understanding of renal health but also paves the way for future innovations in the medical field.